<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/ptct" ></link>
<id>urn:uuid:68aadea9-5783-01ae-5fe6-608d0df3cbb9</id>
<updated>2026-08-25T16:18:26-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>PTCT: SCHMERTZLER MICHAEL (DIR) Sold (AS) 25k Shares of PTC THERAPEUTICS INC for $70.78-$72.92 on 8/19-8/20</title>
<link href="http://www.insiderinsights.com/company/ptct/ptc-therapeutics-inc/id-6458600" ></link>
<id>urn:uuid:df1408fc-01b6-9fad-63a6-1252d44afecc</id>
<updated>2026-08-21T17:20:05-04:00</updated>
<summary type="html" ><![CDATA[PTC THERAPEUTICS INC (PTCT). Recent Price: $69.82. Mkt Cap:5.8B. 10D Vol: 853,660]]></summary>
</entry>
<entry>
<title>PTCT: BOULDING MARK ELLIOTT (VP,LO) Exercised 2,813 Options (OE) of PTC THERAPEUTICS INC for $25.69 on 8/17, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/ptct/ptc-therapeutics-inc/id-6457215" ></link>
<id>urn:uuid:96ae74ba-2955-9586-0f08-be195f05b4a8</id>
<updated>2026-08-19T17:20:05-04:00</updated>
<summary type="html" ><![CDATA[PTC THERAPEUTICS INC (PTCT). Recent Price: $69.82. Mkt Cap:5.8B. 10D Vol: 853,660]]></summary>
</entry>
<entry>
<title>PTCT: KLEIN MATTHEW B (CEO,DIR) Sold (AS) 10,292 Shares of PTC THERAPEUTICS INC for $68.57 on 8/4</title>
<link href="http://www.insiderinsights.com/company/ptct/ptc-therapeutics-inc/id-6450196" ></link>
<id>urn:uuid:2bcd5215-d412-2da7-daee-630e8e8a8c14</id>
<updated>2026-08-06T17:20:06-04:00</updated>
<summary type="html" ><![CDATA[PTC THERAPEUTICS INC (PTCT). Recent Price: $69.82. Mkt Cap:5.8B. 10D Vol: 853,660]]></summary>
</entry>
<entry>
<title>PTCT: SOLLIE ZETLMAYER HEGE ELISABETH (DIR) Acquired (JB) 6k Shares of PTC THERAPEUTICS INC for $0.00 on 7/28</title>
<link href="http://www.insiderinsights.com/company/ptct/ptc-therapeutics-inc/id-6446663" ></link>
<id>urn:uuid:c7cee931-ea6e-e80e-6f4f-c896f2d67970</id>
<updated>2026-07-30T21:02:17-04:00</updated>
<summary type="html" ><![CDATA[PTC THERAPEUTICS INC (PTCT). Recent Price: $69.82. Mkt Cap:5.8B. 10D Vol: 853,660]]></summary>
</entry>
<entry>
<title>PTCT: SOLLIE ZETLMAYER HEGE ELISABETH (DIR) Filed a Form 3, Becoming a Registered Insider at PTC THERAPEUTICS INC With Initial Direct Holdings of 46,526</title>
<link href="http://www.insiderinsights.com/company/ptct/ptc-therapeutics-inc/id-6446657" ></link>
<id>urn:uuid:9c72483d-c74e-4442-5800-004399eeabb5</id>
<updated>2026-07-30T21:00:16-04:00</updated>
<summary type="html" ><![CDATA[PTC THERAPEUTICS INC (PTCT). Recent Price: $69.82. Mkt Cap:5.8B. 10D Vol: 853,660]]></summary>
</entry>
<entry>
<title>PTCT: GRAVIER PIERRE (CFO) Sold (AS) 3,494 Shares of PTC THERAPEUTICS INC for $80.35 on 7/14</title>
<link href="http://www.insiderinsights.com/company/ptct/ptc-therapeutics-inc/id-6442306" ></link>
<id>urn:uuid:d418e227-5d31-0697-9159-053e7170eedc</id>
<updated>2026-07-16T17:20:06-04:00</updated>
<summary type="html" ><![CDATA[PTC THERAPEUTICS INC (PTCT). Recent Price: $69.82. Mkt Cap:5.8B. 10D Vol: 853,660]]></summary>
</entry>
<entry>
<title>PTCT: SMITH MARY L (DIR) Exercised 15,834 Options (OE) of PTC THERAPEUTICS INC for $42.95 on 7/9, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/ptct/ptc-therapeutics-inc/id-6441085" ></link>
<id>urn:uuid:56207308-7dfd-b1ab-23ff-3befe251dcce</id>
<updated>2026-07-13T17:20:09-04:00</updated>
<summary type="html" ><![CDATA[PTC THERAPEUTICS INC (PTCT). Recent Price: $69.82. Mkt Cap:5.8B. 10D Vol: 853,660]]></summary>
</entry>
</feed>